На AIDS 2018 обсудили стратегию расширения доступа к АРВ-препаратам в странах ВЕЦА
940  

На AIDS 2018 обсудили стратегию расширения доступа к АРВ-препаратам в странах ВЕЦА

Несмотря на активное развитие адвокационной деятельности и понимание проблематики государственными структурами, регион ВЕЦА все еще сталкивается с трудностями по достижению целей 90-90-90, которые при сохранении нынешнего статуса-кво могут стать непреодолимыми.

July 24, 2018
The continuum of HIV care: how is Europe doing?
1034  

The continuum of HIV care: how is Europe doing?

​The continuum of HIV care is a framework that enables countries to monitor the effectiveness of their HIV response - from diagnosis towards viral suppression (which means that the virus is no longer detectable in the blood). This report provides a snapshot of the status ...

April 25, 2017

New research shows abnormal immune activation even in very early HIV infection

Even in very early (acute) HIV infection—before fourth generation HIV test assays are able to detect an HIV infection—immune activation and inflammatory processes may already be occurring, new research shows. And, very early antiretroviral therapy (ART) may reduce, although not fully suppress, production of inflammatory markers ...

January 19, 2017
EATG  EATG  EATG  EATG  EATG  EATG  EATG  Uncategorized  News  News  News  News  News  News  

Successful antibody trial in HIV-infected individuals

A research team led by investigators of the Rockefeller University in New York and Prof Florian Klein, University Hospital Cologne and German Center for Infection Research (DZIF), has tested a new HIV neutralising antibody, called 10-1074, in humans. The results of the trial have just ...

January 19, 2017

UNAIDS Board considers recommendations on access to medicines

The Board of the Joint United Nations Programme on HIV/AIDS (UNAIDS) this week is considering a report calling for the 11 cosponsor agencies of the programme to follow the recommendations of the UN Secretary General’s High-Level Panel on Access to Medicines to improve policy coherence, ...

December 07, 2016

HIV: The Long View Webinar

EATG-hosted community webinar for HIV: The Long View – Invitation What does the future look like for HIV? Introducing HIV: The Long View As little as three decades ago, there was no such thing as a long-term vision for people living with HIV. Now, thanks ...

September 27, 2016

First generic version of dolutegravir approved by the FDA

Aurobindo Pharma receives US FDA tentative approval for dolutegravir – the first generic version to be approved. This generic dolutegravir is expected to be launched in sub-Saharan Africa in late 2016 through a collaboration between Aurobindo, ViiV Healthcare, and the Clinton Health Access Initiative (CHAI). The WHO ...

September 27, 2016

October 2016 issue of The Lancet HIV now online

The Lancet HIV is an exclusively online journal dedicated to publishing original research that advocates change in, or illuminates, HIV clinical practice. It publishes translational, epidemiological, clinical, operational, and implementation studies. The October 2016 issue is available here. Original Article

September 27, 2016